Abstract. We expressed the synaptic vesicle proteins SV2, synaptotagmin, and synaptophysin in CHO fibroblasts to investigate the targeting information contained by each protein. All three proteins entered different cellular compartments. Synaptotagmin was found on the plasma membrane. Both SV2 and synaptophysin were sorted to small intracellular vesicles, but synaptophysin colocalized with early endosomal markers, while SV2 did not. SV2-containing vesicles did not have the same sedimentation characteristics as authentic synaptic vesicles, even though transfected SV2 was sorted from endosomal markers. We also created cell lines expressing both SV2 and synaptotagmin, both synaptotagmin and synaptophysin, and lines expressing all three synaptic vesicle proteins. In all cases, the proteins maintained their distinct compartmentalizations, were not found in the same organdie, and did not create synaptic vesicle-like structures. These results have important implications for models of synaptic vesicle biogenesis.
M
UCH local neuronal communication occurs via chemical signaling. Small messenger molecules, or classical neurotransmitters, are concentrated in small, clear vesicles that fuse with the plasma membrane and release their contents in response to cellular demand. Once the transmitter is released, vesicles are reformed locally, refilled and can undergo multiple signaling cycles. The mechanisms controlling synaptic vesicle formation and recycling are poorly understood. We do know that mature synaptic vesicles contain a specific, well characterized set of integral membrane proteins (SiJdhof and Jahn, 1991) , but it is not clear how this composition is achieved and maintained.
One clue has come from the analysis of non-neuroendocrine cells transfected with the synaptic vesicle-specific protein synaptophysin (p38). Synaptophysin is sorted to a small, endocytic vesicle population when expressed in most nonneuroendocrine cell lines (Leube et al., 1989; Johnston et al., 1989; Clift-O'Grady et al., 1990; Cameron et al., 1991; Linstedt and Kelly, 1991) . This result shows that nonneuronal cells can recognize and sort synaptic vesicle proteins, and further suggests that synaptic vesicles are endocytosed through conventional coated pit recycling with endocytic markers like the transferrin receptor, and are later restricted to a distinct vesicle population. In addition, these findings suggest that synaptic vesicles evolved from a common recycling pathway present in many cells.
Fibroblasts expressing synaptophysin sort the protein to small intracellular vesicles, but those vesicles do not have the same size and sedimentation behavior as authentic synaptic vesicles (Clift-O'Grady et al., 1990; Cameron et al., 1991; Linstedt and Kelly, 1991) . A remarkable characteristic of synaptic vesicles is their extremely uniform 40-nm diameter and round shape. Endosomes, on the other hand, are typically larger and have a tubulo-vesicular morphology. The difference in size and shape allows synaptic vesicles to be separated from endosomes by differential centrifugation. Synaptophysin from transfected fibroblasts is recovered in the endosomal fractions, rather than in a neuronal-type vesicle population. Although synaptophysin may contribute endosomal targeting signals to the synaptic vesicle, expression of synaptophysin does not direct the formation of a small, uniform synaptic vesicle-like organdie. Another synaptic vesicle protein might play this role. Alternatively, formation of neuronal-type vesicles may require the coexpression of other synaptic vesicle proteins, and might be detected in cell lines programmed to make more than one synaptic vesicle protein.
Fibroblastic cell lines expressing combinations of the synaptic vesicle proteins would also help to clarify the significance of multimeric synaptic vesicle protein interactions observed in vitro. Solubilization of synaptic vesicle membranes in several different detergents leads to the recovery of large protein complexes that include the synaptic vesicle proteins SV2, synaptotagmin, synaptophysin, and rab3A, as well as the vacuolar proton pump and various unidentified components (Bennett et al., 1992a) . It was calculated that the majority of the protein in synaptic vesicles could be contained in as few as three of these complexes. If these complexes exist in vivo, they could be extremely important in all aspects of synaptic vesicle function, including biogenesis and recycling.
We have created fibroblastic CHO cell lines that express the synaptic vesicle proteins SV2, synaptotagmin, and synaptophysin to test the generality of endosomal synaptic vesicle protein sorting in non-neuroendocrine ceils, and to discover if either SV2 or synaptotagmin can create a synaptic vesicle-like compartment in a foreign environment. In addition, we generated cell lines that coexpress combinations of three synaptic vesicle proteins, as well as all three together, to determine if formation of synaptic vesicle-like structures requires expression of multiple synaptic vesicle proteins. These lines also allow us to test the abilities of specific synaptic vesicle proteins to form complexes with one another in vivo. SV2 is a highly glycosylated integral membrane protein (Buckley and Kelly, 1985) . Sequence analysis revealed that the protein is highly homologous to a group of 12 transmembrane domain prokaryotic and eukaryotic transporters including the human glucose transporter (Bajjalieh et al., 1992; Feany et al., 1992; Gingrich et al., 1992) . It seems likely that SV2 functions as a transporter, although its substrate(s) has not been identified, and additional channel or enzymatic functions have not been excluded. Synaptotagmin (p65; Matthew et al., 1981) , in contrast, appears to be intimately involved in membrane fusion events during synaptic vesicle exoeytosis. The protein contains a single transmembrane domain and a cytoplasmic region that has two copies of a region similar to the C2 domain of the phospholipiddependent protein kinase C (Perin et al., 1990) . Synaptotagmin binds both acidic phospholipids and calcium (Brose et al., 1992) , and is found in a complex with the oMatrotoxin receptor (neurexin; Ushkaryov et al., 1992) . ~latrotoxin is a vertebrate neurotoxin that induces massive exocytosis (Petrenko et al., 1991) . Synaptophysin is thought to be involved in a different stage of neurotransmitter release. Based on its topological similarity to gap junctions and its ability to form voltage-dependent channels in black lipid membranes (Thomas et ai., 1988) , synaptophysin may form a mast cell-like fusion pore, perhaps in combination with the synaptic plasma membrane protein physophilin (Thomas and Betz, 1990) . Our data indicate that fibroblasts sort each of the three synaptic vesicle proteins independently, perhaps in keeping with their diverse roles. SV2 appears in a small vesicle population distinct from synaptophysin and synaptic vesicles, and synaptotagmin is targeted to the plasma membrane.
Materials and Methods

Primary Antibodies
mAbs to synaptophysin (SY38) and tubulin and polyclonal antibodies to human transferrin were from Boehringer Mannheim (Mannheim, Germany). ER antibodies were from Jennifer Lippincott-Schwartz (National Institutes of Health, Bethesda, MD). Kelley Moreman (University of Georgia, Athens, GA) donated the anti-mannisodase II antiserum. A mAb to clathrin (CHc5.9) was from BIODESIGN International (Kennebunkport, ME). A mAb directed against the cytoplasmic epitope of the human transferrin receptor (H68.4) was the kind gift of Ian Trowbridge (Salk Institute, La Jolla, CA). William Brown (Cornell University, Ithaca, NY) donated the anti-mannose-6-phospbate receptor antibody. The mAb E9a4 antibody to the lysosomal protein IglO5 was a girl of Brigitte Foellmer (Yale University, New Haven, CT). Reinhard Jahn (Yaie University) donated the mAb C141.1 against synaptotagmin. The synaptotagmin ectopeptide antiserum against the lumenal domain of the protein was from Pietro De Camiili (Matteoli et ai., 1992; Yaie University) . A polyclonai antiserum to synaptophysin was the gift of Dan Cutler (MRC, London, England). The anti-low density lipoprotein (LDL) l receptor (4A4) antibody was from the American Type Culture Collection (ATTC; Rockland, MD).
Cell Culture and Transfection
CHO-K1 (ATCC) cells were grown in glutamine-free Glasgow MEM (GMEM) (GIBCO-BRL, Gaithersburg, MD) before transfection. To obtain a eDNA encoding synaptotagmin for transfection, the synaptotagmin coding region was amplified from a rat brain eDNA library by the PCR. The synaptotagmin clone was sequenced and two changes were found from the predicted amino acid sequence of the previously published rat eDNA (Perin et ai., 1990) : E188 changed to D, and D374 was aitered to G. It is unlikely that these substitutions are PCR-induced errors because both are conserved in the human and Drosophila sequences (Perin et ai., 1991) . The synaptotagmin eDNA was subcloned into the expression vector pEEl4 (Celltech, Berkshire, UK), CHO-K1 ceils transfected using Lipofectin (GIBCO-BRL) and stable transformants were selected in the presence of 25/zM methionine sulphoximine (MSX). Lines were subcloned until 100% of the cells expressed synaptotagmin by immunocytochemistry using alkaline pbosphatase detection. A synaptopbysin eDNA obtained from A. Linstedt and R. Kelly (Clift-O'Grady et ai., 1990) was also expressed in CHO cells using the pEEl4 expression vector (Bebbington and Hentschel, 1987; Stephens and Cocker, 1989) .
The vector CDM8 was used to express SV2 (Feany et ai., 1992) . To obtain stable cell lines expressing multiple synaptic vesicle proteins, CHO-K1 cells or ceils expressing SV2 were transfected with the appropriate synaptotagmin and/or synaptophysin expression plasmids. Cell lines were selected and subcloned as above. All cell lines were maintained in GMEM; synaptotagnun and synaptophysin cells were supplemented with 25 ~M MSX.
Several independent isolates of each ceil line were analyzed to ensure reproducibility. All isolates exhibited similar sorting patterns, and were selected for high expression levels only.
Actin microfilaments were disrupted by a 2-h treatment with 10 ~g/ml dihydrocytochaiasin B (Sigma Chemical Co., St. Louis, MO). Nocodozole (Sigma Chemical Co.) treatment was also for 2 h in 10 ~g/mi of the drug.
Immunofluorescence Labeling
For immunofluorescence analysis cells were typically grown overnight on poly-L-lysine-coated glass coversilps, washed in PBS, fixed in 4% formaldehyde, permeabilized in a buffer containing 500 raM NaC1, 20 mM sodium phosphate, pH 7.4, and 0.3% Triton X-100, incubated with primary antibody overnight at 4°C and detected with fluorescein or rhodamineconjugated secondary antibodies (Cappel Laboratories, Durham, NC) in the same buffer (Cameron et ai., 1991) . For transferrin uptake experiments, cells were starved for 1 h in serum-free medium, incubated for an additional hour in serum-free medium supplemented with 20 t~g/mi iron saturated human transferrin (Sigma Chemical Co.) at 37°C at 10% C(>z. Cells were then washed quickly in ice-cold PBS, fixed, and processed for immunofluorescence. Actin was visualized using rhodamine-phalloidin (Molecular Probes, Inc., Eugene, OR).
Gradient Fractionation and OrganeUe Immunoisolation
For gradient fractionation cells were harvested in homogenization buffer containing 100 mM NaC1, 10 mM Hepes, pH 7.4, 1 mM EDTA, 0.1 mM MgCI2. The cells were then homogenized in homogenization buffer with 1 mM PMSF, 10 ng/ml aprotinin, pepstatin, and leupepfin, by 10 passes past a cell cracker (Bernl-Tech Engineering, Saratoga, CA) bail bearing with a 12-#m clearance. Unbroken cells and debris were removed with a 5-rain spin at 2,000 g. Postnuclear supernatants were loaded on 10-50% sucrose gradients or 5-25% glycerol gradients with a sucrose pad. Glycerol gradients were spun for 1 h at 48,000 rpm in a SWS0.1 rotor at 4°C; sucrose gradients were spun at least 15 h at 48,000 rpm in the same rotor, at the same temperature. For organeile immunoisolation, magnetic IgG-coated beads (Dynal Inc., Great Neck, NY) were incubated in SY38, 4A4 anti-LDL receptor or SV2 antibody overnight. Beads were washed three times in immunoprecipitation buffer containin~ PBS with 10 mM EGTA and 1% BSA, and re.suspended in immunoprecipitation buffer. For all immunoprecipitations, three peak sucrose gradient fractions were pooled (av-1. Abbreviations used in this paper: GMEM, Glasgow MEM; LDL, low density lipoprotein; MSX, methionine sulpboximine. erage approximate density of 1.14 g/cc), and various amounts added to the magnetic beads. The mixture was rotated for 2 h at 4°C. Immunoprecipitated organelles were washed three times in immunoprecipitation buffer and solubilized in SDS-PAGE sample buffer.
Western Blot Analysis
Gradient fractions were precipitated with acetone, resuspended in sample buffer, run on 4-15% gradient polyacrylamide gels and transferred onto nitrocellulose. Blots were blocked for 1 h in 50 mM Tris, pH 7.4, 100 mM NaCI, .05% Tween-20, 2% nonfat dry milk and 2% normal goat serum. Primary antibodies were diluted in the same buffer and incubated on the blots for an additional hour. Synaptophysin was detected with SY'38; synaptotagmin, C1 41.4; transferrin receptor, H68.4. Bound primary antibodies were detected using 125I-labeled goat anti-mouse IgG (New England Nuclear). Signals were quantified using a PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA). The SV2 signal appeared as a high molecular weight smear, and was quantified by selecting the molecular weight range that contained >90% of the total SV2 signal and scanning this same region on each blot. Synaptotagmin was quantified by scanning the 65-kD band.
Samples in the blot shown in Fig. 2 were electrophoresed, blotted, and detected in parallel to allow comparison of expression levels.
Electron Microscopy
Membranes from the peak sucrose gradient fraction were diluted in homogenization buffer and pelleted for 1 h in an airfuge (150000 g). Pellets were fixed in freshly prepared 4% formaldehyde, washed with PBS, and blocked for 1 h in PBS with 1% BSA. Membranes were incubated at 4°C overnight with SY38 or anti-SV2, washed three times, incubated for 1 h with gold-conjugated goat anti-mouse IgG, washed three additional times, and processed for electron microscopy as follows. Cell pellets were fixed in 2.5% glutaraldehyde in 100 mM cacodylate buffer, pH 7.4, for 30 rain. After a brief wash in PBS, the pellets were postfixed in osmium-ferrocyanide (Karnovsky, M. J. 1971. J. Cell Biol. 51:146a)for 1 h at room temperature. The cells were then stained en bloc in 1% uranyl acetate in maleate buffer, pH 6.0, for 1 h at room temperature. Subsequently, the pellets were dehydrated in ethanol and embedded in epon-araldite. Ultrathin sections were stained with uranyl acetate and lead citrate, and examined in a JEOL 100CX electron microscope 0EOL Ltd., Tokyo, Japan). Cells which were grown on glass coverslips were processed as described above for cell pellets, except that fixation consisted of 2% formaldehyde, 1% glutaraldehyde in 100 mM cacodylate buffer, pH 7.4.
Surface Biotinylation
One confluent 10-cm plate each of SV2 or synaptotagmin expressing CHO cells was washed three times in 50 mM sodium borate, 150 mM NaC1, pH 9.0, and biotinylated by two 15-min incubations at 0*C in 0.5 mg/ml NHS-SS-biotin in borate buffer. Cells were washed, removed in Ca2+/Mg 2÷ free PBS, pelleted, membranes sohibilized in 1% NP-40, 0.4% deoxycholate, 66 mM EDTA, 10 mM Tris-HCl, pH Z4, and divided into two aliquots. The first was immunoprecipitated with antibodies to SV2 or synaptotagmin, and used for determination of total synaptic vesicle protein. The second was treated first with streptavidin agarose and the nonbinding fraction was then immunoprecipitated with antibodies to the synaptic vesicle proteins. Immunoprecipitated material and proteins precipitated by streptavidin agarose were solubilized in SDS-PAGE sample buffer, processed for Western blot analysis and quantitated as above. Percentage of cell surface protein was calculated as the fraction of the total synaptic vesicle protein bound to streptavidin agarose. Values plotted are the mean of three determinations plus or minus the standard error.
Results
lmmunofluorescent Localization of SV2 and Synaptotagmin
To investigate the targeting information contained in the SV2 and synaptotagmin primary sequences, we expressed both proteins in CHO fibroblasts. Cell lines expressing synaptophysin were used as controls. Previous experiments demonstrated that synaptophysin enters an endosomal compartment in fibroblasts (Leube et al., 1989; Johnston et al., 1989; Clift-O'Grady et al., 1990; Cameron et al., 1991; Linstedt and Kelly, 1991) . The intracellular localization of the transfected proteins was examined by immunofluorescence. SV2 (Fig. 1 A) accumulated primarily intraceUularly and, like synaptophysin ( Fig. 1 B) had a punctate perinuclear and cytoplasmic fluorescent staining pattern. In contrast, synaptotagmin was found in the plasma membrane and filopodia (Fig. 1 C; Feany and Buckle),, 1993). The differences in the three patterns did not appear to result from gross overexpression of the proteins because each protein was expressed at lower levels in CHO cells than in rat brain ( Fig. 2 ; see Materials and Methods).
To more precisely localize SV2, we compared SV2 fluorescence with a series of proteins known to reside in distinct subcellular compartments. SV2 staining was clearly different from the pattern of a resident ER protein (Fig. 3,  A and B) . Although some SV2 protein did localize to the Golgi region, most of the punctate cytoplasmic reactivity was distinct (Fig. 3, C and D) . SV2 staining was unlike clathrin immunoreactivity (Fig. 3, E and F) , which marks coated pits and vesicles. Similarly, SV2 positive structures did not correspond with the mannose-6-phosphate receptor, a marker for late endosomes and the trans-Golgi region (Fig. 3, K and L), or lysosomes, as scored by a resident lysosomal glycoprotein (Fig. 3, M and N) . The pattern of SV2 fluorescence did seem similar to that of internalized transferrin, a marker of endocytic vesicles (Fig. 3, G and H) , but fluorescent puncta did not exactly correspond. In contrast, synaptophysin immunoreactive puncta appeared to coincide precisely with transferrin positive structures (Fig. 3, I and J). , and synaptotagmin (C) expressed in fibroblastic CHO cells and detected with a mAb to SV2 (Buckley and Kelly, 1985) , SY38, and a rnAb to synaptotagmin (Matthew et al., 1981 
Gradient Fractionation of SV2 and Synaptotagmin Expressing Cells
To more carefully define the compartments containing the transfected proteins, and to monitor the possible genesis of a synaptic vesicle-like organelle, we performed gradient fractionation of the transfected cell lines. When CHO cells expressing synaptophysin were fractionated on a shallow 10-50% linear sucrose gradient a single sharp peak of synaptophysin immunoreactivity was detected by Western blot analysis (Fig. 4 A) . This peak corresponded exactly to the peak of transferrin immunoreactivity, suggesting that the two proteins occupied the same intraceUular compartment. In contrast, SV2 immunoreactivity appeared as a much broader peak (Fig. 4 B) . Much of the protein fractionated at the same density as the transferrin receptor; however, some SV2 was found in organelles with a higher density. Synaptotagmin also fractionated as a broad peak on sucrose gradients (Fig.  4 C) . Again, a portion of the protein was in fractions that had the same density as the transferrin receptor containing endosomes, but a substantial percentage was not.
The rat pheochromocytoma cell line (PC12) has been a useful source of synaptlc vesicle-like structures for biochemical characterization. The synaptophysin protein is found in two distinct compartments in this cell line. One cofraction- 
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ates with and contains endosomal markers, the other migrates with authentic synaptic vesicles and contains other synaptic vesicle proteins (Clift-O'Grady et al., 1990; Cameron et al., 1991; Linstedt and Kelly, 1991) . By sucrose density gradient analysis both populations of vesicles migrated as one rather broad peak (Fig. 4 D) . However, the different sedimentation coefficients allow the two vesicle populations to be resolved on a glycerol velocity gradient (Fig. 4 H) . The synaptic vesicle-like population was seen in the upper portions of the gradients and contains SV2, synaptotagmin and synaptophysin, but not transferrin receptor. The synaptic vesicle-like fractions were relatively enriched for synaptophysin as compared with the other two synaptic vesicle proteins.
We confirmed previous reports that synaptophysin is not sorted to a synaptic vesicle-like compartment in CHO cells by separating synaptophysin homogenate on a glycerol gradient (Fig. 4 E) . SV2 and synaptotagmin homogenates were also fractionated on glycerol gradients to determine if SV2 and/or synaptotagmin were contained in a vesicle population with the same sedimentation behavior as synaptic vesicles. All of the SV2 and synaptotagmin immunoreactivities were recovered in the heavier fractions that also contain transferfin receptor (Fig, 4, F and G) . None of the three synaptic vesicle proteins directed the formation of an organelle with the same sedimentation characteristics as authentic synaptic vesicles.
Immunoelectron Microscopic Localization of SV2 and Synaptotagmin
To further characterize the SV2 containing organelles we performed immunoelectron microscopy on membranes found in the peak fraction of SV2 sucrose gradients. Gold-labeled membranes consisted of vesicles with average diameters of ,,o80 nm (Fig. 5 A) . These vesicles were the same size and shape as synaptophysin containing vesicles fractionated and labeled in a similar manner (Fig. 5 B) . No consistent labeling of membranes was seen when cells transfected with vector alone were incubated with the SV2 antibody and goldconjugated secondary antibody (Fig. 5 C) , or when SV2 containing membranes were incubated with the secondary antibody only. We did not observe significant labeling of SV2 containing membranes from the heavier sucrose gradient fractions. The concentration of SV2 in those membranes may have been below our detection limit.
Some synaptotagmin cofractionated with early endosomes as defined by transferrin receptor immunoreactivity (Fig. 4  C) . To determine if this synaptotagmin was actually in an intracellular, endosomal compartment not apparent on visual inspection of immunofluorescently labeled cells, we used antibodies that recognize the lumenal, or extraceUular domain of synaptotagmin (Matteoli et al., 1992) . This antiserum has been used to monitor multiple rounds of exoand endocytosis in neuronal cells. To identify endocytosed synaptotagrnin ceils were incubated with the primary antibody at 37°C for 1 h, followed by a subsequent incubation with the gold-conjugated secondary antibody at 37°C. This procedure should label synaptotagmin that is endocytosed from the plasma membrane during the second 37°C incubation, as well as any continuously recycling protein. In contrast to the results obtained with neurons, we failed to find a significant amount of labeled synaptotagmin inside the cell. A few small vesicular profiles and multivesicular bodies were labeled (Fig. 5 E) , but the majority of the gold particles were confined to the plasma membrane (Fig. 5 D) .
OrganeUe Immunoisolation Confirms that SV2, Synaptotagmin, and Synaptophysin Are Not in the Same Compartment
To confirm that the SV2 protein occupies a vesicular compartment distinct from early endosomes, we used an antibody that recognizes the cytoplasmic tail of the LDL receptor to immunoprecipitate endosomal organelles. While LDL receptor antibody-coated beads removed all of the synaptophysin from peak sucrose gradient fractions, they did not precipitate any of the SV2 (Fig. 6 A) . Similarly, although LDL receptor antibody removed an average of 90% of the LDL receptor protein, it did not precipitate synaptotagmin from sucrose gradient fractions containing synaptotagmin and transferrin receptor. Immunoprecipitation of plasma membrane LDL receptor should also precipitate synaptotagmin, but we did not observe significant coimmunoprecipitation. It may be that the transferrin receptor containing gradientt fractions used were not highly enriched in plasma membrane. Control beads coated with nonspecific mouse immunoglobulin did not precipitate any of the proteins (Fig.  6 A) . To further compare the synaptophysin and SV2 containing organelles, magnetic beads were coated with anti- bodies against synaptophysin or SV2, and these beads were used to immunoprecipitate synaptophysin and SV2 membranes (Fig. 6, B and C) . Most of the synaptic vesicle proteins were precipitated by the appropriate beads. In addition, synaptophysin beads removed most of the transferrin receptor, while SV2 beads did not.
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Analysis of Cell Lines Expressing Mulffple Synaptic Vesicle Proteins
When SV2, synaptotagmin, and synaptophysin are expressed singly in fibroblast cell lines they inhabit different cellular compartments. If interactions between the proteins are important in segregating the proteins to the same vesicle, coexpression of one synaptic vesicle protein might alter the distribution of another. We created cell lines that express both SV2 and synaptotagmin, both SV2 and synaptophysin, both synaptotagmin and synaptophysin, and all three proteins together. Immunofluorescent localization revealed that neither SV2 nor synaptophysin coexpression altered the plasma membrane localization of synaptotagmin (Fig. 7, A-D). SV2 and synaptophysin also retained their characteristic punctate cytoplasmic fluorescence patterns. Similarly, in cell lines expressing all three proteins, synaptotagmin was localized to the plasma membrane while SV2 and synaptophysin were retained in an intracellular compartment. The lines that expressed both SV2 and synaptophysin allowed a Gradient fractions were treated with beads coated with specific antibody (m) and with beads coated with nonspecific immunoglobulin (~). The percentage of each specific protein recovered from the washed beads is plotted as a fraction of the total synaptic vesicle present in the starting gradient fractions. direct comparison of the immunofluorescence localization of the two proteins. Although the overall patterns of the two proteins were similar (Fig. 3, G and I) , labeling of both in the same cell revealed some overlap but also distinct sets of small puncta (Fig. 7, E and F) .
Immunofluorescence might not be sensitive enough to identify a small amount of protein that was redirected from one compartment to another in the coexpressing lines. Gradient fractionation and organelle immunoprecipitation were therefore used to more carefully characterize the subcellular compartments occupied by the synaptic vesicle proteins. All three proteins were recovered at densities corresponding to their mobilities in singly transfected cell lines after sucrose gradient fractionation (Fig. 8, A-C) . Homogenates from multiply transfected cell lines were then fractionated on glycerol gradients. In each case the synaptic vesicle proteins cofractionated with the transferrin receptor. Even cells expressing SV2, synaptotagmin and synaptophysin failed to sort any of the proteins to a compartment with the same sedimentation behavior as authentic synaptic vesicles (Fig.  8 F) . We also immunoisolated synaptophysin containing organelles from peak sucrose gradient fractions, and found that in a cell line expressing both synaptophysin and synaptotagrain, and in cells expressing all three proteins, the immunoisolated organelles contained very little synaptotagmin or SV2 (Fig. 9) . We cannot exclude the possibility of a small degree of overlap between the organelles containing the three proteins.
Surface Biotinylation Demonstrates that the Majority of the Synaptotagmin Protein Is Found on the Plasma Membrane
Analysis thus far suggested that most synaptotagmin was sorted to the plasma membrane, while SV2 and synaptophysin were located primarily intracellularly. Surface biotinylation of plasma membrane proteins was performed followed by determination of the percentage of total SV2 or synaptotagmin labeled (see Materials and Methods). "¢90% of the synaptotagmin could be surface labeled with biotin, while very little biotinylated SV2 was recovered (data not shown).
Discussion
SF'2 Is Sorted to Small Nonendosomal Vesicles in b'ibroblasts
We expressed the synaptic vesicle protein SV2 in CHO fibroblasts and compared its distribution to those of a variety of intraceUular proteins by immunofluorescence. None of the markers overlapped precisely with SV2 (Fig. 3, A-N) . Internalized transferrin, an early endosomal marker, had the most similar pattern. Several additional methods were used to characterize the SV2 compartment. Sucrose gradient fractionation revealed that the majority of SV2-containing organelles have a density similar to endosomes, as identified by transferrin receptor immunoreactivity (Fig. 4 B) . When SV2 containing membranes from sucrose gradients were labeled with gold-conjugated antibodies and examined by EM, SV2 was localized to a population of small, ,'~80-nm vesicles (Fig. 5 A) . These vesicles appeared similar to organelles that contain synaptophysin in CHO cells (Fig. 5 B) . However, organelle immunoprecipitation showed that the vesicles that contain SV2 do not contain either the transferrin receptor, or the LDL receptor, a second marker of the endosomal compartment (Fig. 6, A and C) . In addition, both immunofluorescence (Fig. 7 , E and F) and organelle immunoprecipitation (Fig. 9 B) demonstrated that the majority of the two proteins occupied distinct subcellular compartments in a cell line expressing both SV2 and synaptophysin.
What is the nature of the SV2 compartment? Although we compared SV2 fluorescence with a wide variety of intracellular markers, completely coincidence staining was never observed. The protein does enter a small, relatively light vesicular compartment. In most nonneuroendocrine cells transfected synaptophysin appears in endosomes, but in some cell lines the protein may create a special vesicle that excludes markers of receptor-mediated endocytosis, and that contains primarily synaptophysin (Leube et al., 1989) . This result would imply that synaptophysin can direct the organization of a special synaptic vesicle-sized organelle. If any of the synaptic vesicle proteins can actually direct the formation of a novel vesicle in non-neuroendocrine cells, our data suggest that SV2 is more likely than synaptophysin to create such an organeUe. SV2 occupies a vesicle that excludes the transferrin and LDL receptors and that has a similar size to synaptic vesicles. However, even if SV2 does segregate to a new organelle, those vesicles do not possess exactly the same biophysical properties as authentic synaptic vesicles. Velocity centrifugation showed that the SV2 vesicles do not have the same sedimentation coefficient as neuronal-type synaptic vesicles (Fig. 4, F and H) . Additional synaptic vesicle proteins may be required to alter the sedimentation coefficient. The other membrane components, if any, of the SV2 organelles will help define these vesicles. Examination of the lifecycle of the vesicles to determine if they are endocytic, and if SV2 passes through a defined endosomal compartment, will also be informative. nation is capable of creating a synaptic vesicle-like compartment in nonneuronal cells. Further analysis of these and other cell lines will refine our understanding of the hierarchy of sorting information required to create and maintain the synaptic vesicle.
